Global Drug Hypersensitivity Reactions Clinical Trials Review, H2, 2015 - Analysis, Technologies & Forecast Report - Key Vendors: Valeant Pharmaceuticals, Ligand Pharmaceuticals & Amgen - Research and Markets

Research and Markets (http://www.researchandmarkets.com/research/b9h828/drug) has announced the addition of the "Drug Hypersensitivity Reactions Global Clinical Trials Review, H2, 2015" report to their offering.

The clinical trial report, "Drug Hypersensitivity Reactions Global Clinical Trials Review, H2, 2015" provides an overview of Drug Hypersensitivity Reactions clinical trials scenario. This report provides top line data relating to the clinical trials on Drug Hypersensitivity Reactions. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

The report enhances the decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

• Provides a snapshot of the global clinical trials landscape
• Provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• Reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• Provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• Provides enrollment trends for the past five years
• Provides latest news for the past three months

Benefits of this Report:

• Assists in formulating key business strategies with regards to investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global, regional and country level

Companies Mentioned:

• Valeant Pharmaceuticals International, Inc.
• Ligand Pharmaceuticals, Inc.
• EMS S.A.
• Amgen Inc.

For more information visit http://www.researchandmarkets.com/research/b9h828/drug

View source version on businesswire.com: http://www.businesswire.com/news/home/20160208005504/en/